752 related articles for article (PubMed ID: 16467338)
21. Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice.
Katzmann JA; Abraham RS; Dispenzieri A; Lust JA; Kyle RA
Clin Chem; 2005 May; 51(5):878-81. PubMed ID: 15774572
[TBL] [Abstract][Full Text] [Related]
22. Serum free light chains: diagnostic and prognostic value in multiple myeloma.
Sthaneshwar P; Nadarajan V; Maniam JA; Nordin N; Gin Gin G
Clin Chem Lab Med; 2009; 47(9):1101-7. PubMed ID: 19728852
[TBL] [Abstract][Full Text] [Related]
23. Assessment of monoclonal gammopathies by nephelometric measurement of individual immunoglobulin kappa/lambda ratios.
Bradwell AR; Harding SJ; Fourrier NJ; Wallis GL; Drayson MT; Carr-Smith HD; Mead GP
Clin Chem; 2009 Sep; 55(9):1646-55. PubMed ID: 19617289
[TBL] [Abstract][Full Text] [Related]
24. Assessment of serum free light chain assays for plasma cell disorder screening in a Veterans Affairs population.
Abadie JM; Bankson DD
Ann Clin Lab Sci; 2006; 36(2):157-62. PubMed ID: 16682511
[TBL] [Abstract][Full Text] [Related]
25. Differences identified between serum and urine immunofixation electrophoresis.
Tracy E; Andrews DM; Constantin MA; Zhu Y
Clin Chim Acta; 2015 Jan; 439():68-70. PubMed ID: 25307209
[TBL] [Abstract][Full Text] [Related]
26. Capillary electrophoresis/immunosubtraction as a better alternative to immunofixation for detecting and immunotyping serum monoclonal proteins in patients with immunoglobulin light chain (AL) amyloidosis.
Miyazaki K; Suzuki K
Amyloid; 2016 Dec; 23(4):221-224. PubMed ID: 27682970
[TBL] [Abstract][Full Text] [Related]
27. A new concept for detection of Bence Jones proteinuria in patients with monoclonal gammopathy.
Hofmann W; Garbrecht M; Bradwell AR; Guder WG
Clin Lab; 2004; 50(3-4):181-5. PubMed ID: 15074473
[TBL] [Abstract][Full Text] [Related]
28. The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma.
Bergón E; Miravalles E; Bergón E; Miranda I; Bergón M
Clin Chem Lab Med; 2005; 43(1):32-7. PubMed ID: 15653439
[TBL] [Abstract][Full Text] [Related]
29. Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure.
Hutchison CA; Plant T; Drayson M; Cockwell P; Kountouri M; Basnayake K; Harding S; Bradwell AR; Mead G
BMC Nephrol; 2008 Sep; 9():11. PubMed ID: 18808676
[TBL] [Abstract][Full Text] [Related]
30. Interference of daratumumab in monitoring multiple myeloma patients using serum immunofixation electrophoresis can be abrogated using the daratumumab IFE reflex assay (DIRA).
van de Donk NW; Otten HG; El Haddad O; Axel A; Sasser AK; Croockewit S; Jacobs JF
Clin Chem Lab Med; 2016 Jun; 54(6):1105-9. PubMed ID: 26812873
[TBL] [Abstract][Full Text] [Related]
31. Quantification of serum free light chain kappa and lambda by the SPAPLUS analyser.
Maisin D; Lepoutre T; Gruson D; Wallemacq P
Clin Biochem; 2013 May; 46(7-8):622-6. PubMed ID: 23291296
[TBL] [Abstract][Full Text] [Related]
32. Long-term biological variation of serum protein electrophoresis M-spike, urine M-spike, and monoclonal serum free light chain quantification: implications for monitoring monoclonal gammopathies.
Katzmann JA; Snyder MR; Rajkumar SV; Kyle RA; Therneau TM; Benson JT; Dispenzieri A
Clin Chem; 2011 Dec; 57(12):1687-92. PubMed ID: 21980167
[TBL] [Abstract][Full Text] [Related]
33. Serum Free Light Chain Assay: Shift Toward a Higher κ/λ Ratio.
Rindlisbacher B; Schild C; Egger F; Bacher VU; Pabst T; Leichtle A; Andres M; Sédille-Mostafaie N
J Appl Lab Med; 2020 Jan; 5(1):114-125. PubMed ID: 32445339
[TBL] [Abstract][Full Text] [Related]
34. Quantitation of serum free light chains does not compensate for serum immunofixation only when screening for monoclonal gammopathies.
Böer K; Deufel T
Clin Chem Lab Med; 2009; 47(9):1109-15. PubMed ID: 19728853
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and progression of monoclonal gammopathy of undetermined significance and light-chain MGUS in Germany.
Eisele L; Dürig J; Hüttmann A; Dührsen U; Assert R; Bokhof B; Erbel R; Mann K; Jöckel KH; Moebus S;
Ann Hematol; 2012 Feb; 91(2):243-8. PubMed ID: 21789623
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of a new free light chain ELISA assay: bringing coherence with electrophoretic methods.
Jacobs JFM; de Kat Angelino CM; Brouwers HMLM; Croockewit SA; Joosten I; van der Molen RG
Clin Chem Lab Med; 2018 Jan; 56(2):312-322. PubMed ID: 28771430
[TBL] [Abstract][Full Text] [Related]
37. Can serum free light chains replace urine electrophoresis in the detection of monoclonal gammopathies?
Beetham R; Wassell J; Wallage MJ; Whiteway AJ; James JA
Ann Clin Biochem; 2007 Nov; 44(Pt 6):516-22. PubMed ID: 17961305
[TBL] [Abstract][Full Text] [Related]
38. Serum Free Light Chain Assay and κ/λ Ratio Performance in Patients Without Monoclonal Gammopathies: High False-Positive Rate.
Singh G
Am J Clin Pathol; 2016 Aug; 146(2):207-14. PubMed ID: 27473738
[TBL] [Abstract][Full Text] [Related]
39. Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine.
Bradwell AR; Carr-Smith HD; Mead GP; Tang LX; Showell PJ; Drayson MT; Drew R
Clin Chem; 2001 Apr; 47(4):673-80. PubMed ID: 11274017
[TBL] [Abstract][Full Text] [Related]
40. Relationship between monoclonal gammopathy and cardiac amyloid type.
Maleszewski JJ; Murray DL; Dispenzieri A; Grogan M; Pereira NL; Jenkins SM; Judge DP; Caturegli P; Vrana JA; Theis JD; Dogan A; Halushka MK
Cardiovasc Pathol; 2013; 22(3):189-94. PubMed ID: 23102805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
